SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record-high vehicle deliveries for December and the fourth quarter, significantly surpassing previous figures and nearing one million cumulative vehicles. This strong performance, further supported by extended EV subsidies in China, is driving considerable community discussion and optimism about the company's path to profitability and its competitive standing in the electric vehicle market.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc. is trending following news of a strategic manufacturing partnership set to scale production of its drug screening reader for anticipated U.S. market entry. The community is actively discussing the stock's massive volume and micro-float, fueling excitement for potential short-squeeze-like parabolic gains. However, a recent private placement with lower-priced warrants has sparked debate among traders, creating a highly volatile environment with divided opinions on its immediate future.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is currently a hot topic, with community discussion centering on the ongoing delay and mixed initial data for its inhaled cystic fibrosis therapy, ARCT-032, which showed some mucus plug reduction but not significant lung function improvements. Investors are closely monitoring an active trade secret lawsuit against AbbVie, generating widespread hope for a substantial settlement or potential acquisition. Many believe the company's advanced mRNA platform and solid cash runway make the stock deeply undervalued amidst significant short interest.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF is generating significant buzz as investors grapple with its perceived disconnection from the underlying asset. Intense community discussions center on the impact of distributions and the inherent decay of this leveraged product, leading to a polarized debate over its immediate trajectory and risk profile.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending amid intense community discussion following recent developments, including a partial summary judgment in its ongoing litigation and strategic changes to its executive team, which are fueling heightened speculation around a potential acquisition. Investors are closely monitoring progress for its rare disease therapy, MIPLYFFA, toward European market access and a patent term extension, while broadly criticizing management for perceived undervaluation and executive compensation. Despite these concerns, many maintain a bullish outlook, citing the company's significant cash reserves and pipeline assets as indicators of untapped value.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASP Isotopes is trending following recent regulatory approvals for its Renergen acquisition, alongside a major firm initiating "Overweight" coverage with a notable price target. The community is actively discussing perceived delays in commercializing key isotopes versus the long-term strategic value of its diverse portfolio spanning nuclear fuel, quantum materials, and helium. Despite recent share price volatility, this blend of strategic acquisitions, analyst validation, and diverse high-demand markets is driving significant investor debate on its future potential.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

SpaceX is trending due to widespread anticipation of a potential IPO in 2026, which is igniting significant speculative interest across the broader aerospace sector. Community discussions are heavily focused on identifying "SpaceX IPO plays," with companies like Momentus ($MNTS) gaining traction for its partnership on Falcon 9 missions and a notably low share count, sparking comparisons to past explosive meme stock surges.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar is a hot topic following a substantial $600 million financing boost and the looming 1-for-30 reverse stock split, which has sparked intense debate among investors. While many are optimistic about strong Q4 delivery numbers for the Polestar 4 and new Google Gemini AI integration, community sentiment remains sharply divided on whether operational improvements can finally overcome persistent skepticism about the stock's performance.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending after definitively agreeing to sell Bressner Technology for $22.4M, a strategic move the community views as a profitable pivot to focus on high-growth AI and edge computing. This substantial cash infusion and sharpened corporate focus are fueling strong anticipation for impending large military contracts, particularly a potential $200M situational awareness system. Investors are actively discussing the company's low float and undervalued status, anticipating significant upside as the AI and defense narrative gains wider recognition.

Analog Devices, Inc. is a semiconductor company, which engages in the combination of analog, digital, and software technologies into engineering solutions. Its products include analog and mixed signals, power management and reference, amplifiers radio frequency, and reference, sensors and actuators, and digital signal processing and system. The company was founded by Raymond P. Stata and Matthew Lorber in 1965 and is headquartered in Wilmington, MA.

Analog Devices Inc.

Analog Devices (ADI) is trending following robust earnings that surpassed expectations, largely driven by strong performance in its industrial and communications segments, significantly propelled by increasing AI-driven chip demand. The investment community views ADI as a "quiet winner" well-positioned within the expanding AI supply chain, with analysts noting its operational excellence and strategic price increases. This sentiment underpins expectations for continued growth, even amidst broader market discussions around semiconductor sector cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Retail sentiment&nbsp;stayed bearish on Foresight Autonomous after the company said it will&nbsp;implement a 1-for-7 reverse share split of its ordinary shares next week to maintain compliance with Nasdaq’s listing requirements.The split will become effective Aug. 24 on the Tel Aviv Stock Exchange and Aug. 25 on the Nasdaq Capital Market.While the split will raise the trading price of the company’s American Depositary Shares (ADS) proportionally, Foresight said it cannot assure that the ADS price will hold on a proportionate basis after implementation.&nbsp;The company noted the reverse split will not affect shareholder voting rights or ownership percentages.No fractional shares will be issued and instead, the depositary will aggregate and sell fractional entitlements and distribute cash proceeds to holders,&nbsp;it added.On Stocktwits, retail sentiment toward the company was ‘bearish’ late Sunday amid ‘low’ message volume, reflecting investor caution around the move.&nbsp;One user questioned whether such a split required shareholder approval, while another suggested the company’s decision to move ahead before extending showed it was focused on securing compliance ahead of possible near-term deals.<stembedurl>https://stocktwits.com/cubsoxbull/message/625444030</stembedurl><stembedurl>https://stocktwits.com/Noone27/message/625427221</stembedurl>The reverse split comes on the heels of a series of technology and commercial partnerships. On Monday, the company announced a three-way agreement with Konec and Gint to co-develop an autonomous tractor control system based on its 3D perception technology.&nbsp;The collaboration could generate up to $35 million in revenue by 2030, with initial sales expected as early as 2026.&nbsp;Earlier this month, the company also secured approval for a $5 million drone development project with India’s Big Bang Boom Solutions, aimed at rugged autonomous drones for industrial inspection.Foresight, through its subsidiaries, develops three-dimensional vision systems and cellular-based accident prevention applications for automotive, defense, agriculture, and UAV markets.&nbsp;Its Eye-Net Mobile unit is working with Toyota and SoftBank on vehicle-to-network technology that could improve hazard detection beyond line-of-sight scenarios.<a href="https://stocktwits.com/symbol/FRSX">Foresight Autonomous’ stock</a> has declined 73.7% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail sentiment stayed bearish on Foresight Autonomous (FRSX) after the company said it will implement a 1-for-7 reverse share split of its ordinary shares. (Photo credit: Getty Images)

Foresight Autonomous Sets Reverse Split To Retain Nasdaq Listing; Retail Traders Eye Compliance Play Ahead Of Deals

The split comes as Foresight advances commercial projects, including a $35 million autonomous tractor collaboration with Konec and Gint.

Equity

This ‘Strong Buy’ Self-Driving Driving Car Stock Just Got a Major Nvidia Boost

Foresight Autonomous stock rallied as much 30% on Monday after announcing plans of integrating Nvidia Jetson Orin.

Foresight Autonomous Holdings Ltd. is engaged in the research and development of vehicular accident prevention products. Its product is QuadSight, a multi-spectral vision solution for detection of obstacles in harsh lightining and weather conditions. The company was founded by Haim Siboni on September 19, 1977 and is headquartered in Ness Ziona, Israel.

FRSX
Foresight Sp ADR

Feed

News

Sentiment

Fundamentals

Info

Latest FRSX News

FRSXForesight Sp ADR